Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

6.8K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
6.8K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

977
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
977
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Methods of Documentation III: PIE01:21

Methods of Documentation III: PIE

2.2K
Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Algorithm Maxima for Intravenous Insulin Infusion.

Diabetes technology & therapeutics·2020
Same author

Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism·2019
Same author

THE DAMPING PARAMETERS CYE (CURB YOUR ENTHUSIASM) AND DSP (DOWNSCALE PRE-EMPTIVELY) FOR BASAL INSULIN THERAPY.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2015
Same author

Treatment of borderline elevated thyrotropin levels.

JAMA internal medicine·2015
Same author

A quadruply-asymmetric sigmoid to describe the insulin-glucose relationship during intravenous insulin infusion.

Journal of healthcare engineering·2014
Same author

Target attainment through algorithm design during intravenous insulin infusion.

Diabetes technology & therapeutics·2013
Same journal

Implementing the SSKIN Bundle in Home Healthcare: A Tool Tutorial for Reducing Pressure Injuries.

Joint Commission journal on quality and patient safety·2026
Same journal

How Collaboration Between Surgeons and Medical Oncologists Affects Outcomes for Patients with Pancreatic Cancer.

Joint Commission journal on quality and patient safety·2026
Same journal

Uneven Compassion and the Emotional Safety of the Healthcare Workforce.

Joint Commission journal on quality and patient safety·2026
Same journal

Development and Implementation of a Machine Learning Model for Prediction of Surgical Case Duration.

Joint Commission journal on quality and patient safety·2026
Same journal

Decreasing Herpes Simplex Virus (HSV) Testing Turnaround Time for Infants in a Hospital Setting: A Continuous Quality Improvement Project.

Joint Commission journal on quality and patient safety·2026
Same journal

Symptom Tracking in Primary Care: Designing and Testing an EHR-Embedded Safety-Net System.

Joint Commission journal on quality and patient safety·2026
See all related articles

Related Experiment Video

Updated: Apr 8, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Process Performance Measures for Inpatient Glucose Management Programs

Susan S Braithwaite1

  • 1Department of Medicine, Division of Endocrinology, University of Illinois at Chicago, Illinois, USA.

Joint Commission Journal on Quality and Patient Safety
|June 25, 2015
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

11.5K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.6K

Related Experiment Videos

Last Updated: Apr 8, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

11.5K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.6K